Mike Eaddy

Michael Eaddy, PharmD, PhD, joined Xcenda in 2001 and, as a Senior Director, now leads the Data Analytics and Trends team. In this role, he collaborates closely with internal colleagues and clients who are responsible for managed markets, health economics, and quality improvement. 

Dr. Eaddy has led more than 30 adherence-based quality and outcomes assessments, completed Markov and Semi-Markov models in oncology, and specializes in advanced statistical techniques. His work includes economic and retrospective analyses, studies assessing the control of unobserved heterogeneity with the use of frailty models, the effects of missing data on the statistical decisions of quality of life data, and the expanded use of the Cochran-Mantel-Haenszell statistic.

Dr. Eaddy brings more than 8 years’ experience evaluating, designing, and implementing retrospective analyses using SAS, STATA, and E-views and more than 5 years’ experience in the manipulation of large public and private administrative databases. He also has extensive clinical experience in bone marrow transplantation and soft-tissue cancer treatments. Dr. Eaddy has focused much of his research in analyzing outcomes in cardiovascular, urological, and mental health disorders.

Dr. Eaddy is an active author and speaker and a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), which recognized his work with a best poster award in 2009. Included among his other awards is “best value proposition” as recognized by one of the three largest US pharmaceutical companies. He has presented symposia for ISPOR and the Academy of Managed Care Pharmacy, and his work has been published in numerous peer-reviewed journals, including the Journal of Managed Care Pharmacy and the Journal of Clinical Psychopharmacology.

At the University of South Carolina, Dr. Eaddy obtained his BS in Pharmacy, his PharmD, and his PhD in Pharmaceutical and Health Outcomes Sciences.